04404183 is referenced by 107 patents and cites 11 patents.

Sustained release pharmaceutical compositions of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl pyrrolidone, carboxyvinyl polymer, hydroxypropylmethyl cellulose phthalate, cellulose acetate phthalate, methyl meta-acrylate meta-acrylic acid copolymer, polyvinylacetal diethylaminoacetate, dimethylaminoethyl meta-acrylate meta-acrylic acid copolymer, 2-methyl-5-vinylpyridinemethyl acrylate meta-acrylic acid copolymer, citric acid, urea, succinic acid and amino acid, and may further contain one basic substance selected from the group consisting of a surface active agent, polyethylene glycol, propylene glycol, glycerin, a glycerin fatty acid ester and a vegetable oil (first embodiment); and in the case where the solid medical material is nicardipine, the composition may consist only of the amorphous nicardipine or a salt thereof without the above compound (second embodiment).

Title
Sustained release pharmaceutical composition of solid medical material
Application Number
165244
Publication Number
4404183
Application Date
July 29, 1982
Publication Date
September 13, 1983
Inventor
Chiharu Sone
Matsudo
JP
Satoru Yoneya
Omiya
JP
Takashi Sonobe
Saitama
JP
Tadayoshi Ohmura
Niiza
JP
Masayoshi Aruga
Ageo
JP
Hiroitsu Kawata
Kawagoe
JP
Agent
Burgess Ryan & Wayne
Assignee
Yamanouchi Pharmaceutical
JP
IPC
A61K 9/58
A61K 9/52
A61K 9/26
A61K 9/14
View Original Source